Literature DB >> 15866865

Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.

Lucia Gargiulo1, Immacolata Longanesi-Cattani, Katia Bifulco, Paola Franco, Rosanna Raiola, Pietro Campiglia, Paolo Grieco, Gianfranco Peluso, M Patrizia Stoppelli, Maria V Carriero.   

Abstract

The urokinase-type plasminogen activator receptor (uPAR) sustains cell migration through its capacity to promote pericellular proteolysis, regulate integrin function, and mediate chemotactic signaling in response to urokinase. We have characterized the early signaling events triggered by the Ser-Arg-Ser-Arg-Tyr (SRSRY) chemotactic uPAR sequence. Cell exposure to SRSRY peptide promotes directional migration on vitronectin-coated filters, regardless of uPAR expression, in a specific and dose-dependent manner, with maximal effect at a concentration level as low as 10 nm. A similar concentration profile is observed in a quantitative analysis of SRSRY-dependent cytoskeletal rearrangements, mostly consisting of filamentous structures localized in a single cell region. SRSRY analogues with alanine substitutions fail to drive F-actin formation and cell migration, indicating a critical role for each amino acid residue. As with ligand-dependent uPAR signaling, SRSRY stimulates protein kinase C activity and results in ERK1/2 phosphorylation. The involvement of the high affinity N-formyl-Met-Leu-Phe receptor (FPR) in this process is indicated by the finding that 100 nm N-formyl-Met-Leu-Phe inhibits binding of D2D3 to the cell surface, as well as SRSRY-stimulated cell migration and F-actin polarization. Moreover, cell exposure to SRSRY promotes FPR-dependent vitronectin release and increased uPAR.alphavbeta5 vitronectin receptor physical association, indicating that alphavbeta5 activity is regulated by the SRSRY uPAR sequence via FPR. Finally, we provide evidence that alphavbeta5 is required for SRSRY-dependent ERK1/2 phosphorylation, whereas it is not required for protein kinase C activation. The data indicate that the ability of uPAR to stimulate cell migration and cytoskeletal rearrangements is retained by the SRSRY peptide alone and that it is supported by cross-talk between FPR and alphavbeta5.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866865     DOI: 10.1074/jbc.M412605200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.

Authors:  Sara Rezzola; Michela Corsini; Paola Chiodelli; Anna Cancarini; Imtiaz M Nawaz; Daniela Coltrini; Stefania Mitola; Roberto Ronca; Mirella Belleri; Liliana Lista; Dario Rusciano; Mario De Rosa; Vincenzo Pavone; Francesco Semeraro; Marco Presta
Journal:  Diabetologia       Date:  2017-01-13       Impact factor: 10.122

2.  Structural basis of interaction between urokinase-type plasminogen activator and its receptor.

Authors:  Cyril Barinka; Graham Parry; Jennifer Callahan; David E Shaw; Alice Kuo; Khalil Bdeir; Douglas B Cines; Andrew Mazar; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2006-08-26       Impact factor: 5.469

3.  The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

Authors:  Nunzia Montuori; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Valeria Visconte; Daniela Alfano; Ada Pesapane; Francesca Wanda Rossi; Salvatore Salzano; Guido Rossi; Pia Ragno
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

Review 4.  Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity.

Authors:  Srgjan Civciristov; Michelle L Halls
Journal:  Br J Pharmacol       Date:  2019-04-05       Impact factor: 8.739

5.  An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.

Authors:  Roberta Mazzieri; Silvia D'Alessio; Richard Kamgang Kenmoe; Liliana Ossowski; Francesco Blasi
Journal:  Mol Biol Cell       Date:  2005-11-02       Impact factor: 4.138

Review 6.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

Review 7.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

8.  Role of formic receptors in soluble urokinase receptor-induced human vascular smooth muscle migration.

Authors:  Enrico A Duru; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2015-02-12       Impact factor: 2.192

Review 9.  Urokinase and its receptors in chronic kidney disease.

Authors:  Guoqiang Zhang; Allison A Eddy
Journal:  Front Biosci       Date:  2008-05-01

10.  Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.

Authors:  Chi-Hui Tang; Marla L Hill; Alexis N Brumwell; Harold A Chapman; Ying Wei
Journal:  J Cell Sci       Date:  2008-10-21       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.